Axe Compute (NASDAQ:AGPU) Stock Price Crosses Below Two Hundred Day Moving Average – Should You Sell?

Axe Compute Inc (NASDAQ:AGPU) shares passed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $6.66 and traded as low as $5.85. Axe Compute shares last traded at $6.05, with a volume of 526,337 shares trading hands.

Analysts Set New Price Targets

AGPU has been the topic of a number of research reports. Wall Street Zen upgraded Axe Compute from a “sell” rating to a “hold” rating in a research report on Monday, August 24th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Axe Compute in a report on Thursday, August 27th. Finally, JonesTrading raised Axe Compute to a “strong-buy” rating in a report on Saturday, September 26th. One research analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

Axe Compute Stock Performance

The business’s 50-day moving average is $10.18 and its 200-day moving average is $6.66. The company has a market capitalization of $70.12 million, a PE ratio of -1.05 and a beta of 3.84.

Axe Compute (NASDAQ:AGPU) last announced its quarterly earnings data on Friday, August 14th. The company reported ($0.87) earnings per share for the quarter. Axe Compute had a negative return on equity of 1,606.56% and a negative net margin of 7,769.61%. The business had revenue of $3.21 million during the quarter.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Axe Compute stock. Vise Technologies Inc. purchased a new stake in shares of Axe Compute Inc (NASDAQ:AGPU) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 53,848 shares of the company’s stock, valued at approximately $612,000. Vise Technologies Inc. owned approximately 0.46% of Axe Compute at the end of the most recent reporting period. 9.04% of the stock is owned by institutional investors.

Axe Compute Company Profile

Predictive Oncology Inc, a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation.